Export 9 results:
Author [ Title
Filters: Author is McCormack, Jennifer [Clear All Filters]
“Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study.”, Trials, vol. 21, no. 1, p. 289, 2020.
, “Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.”, Addiction, vol. 111, no. 8, pp. 1416-27, 2016.
, “Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods”, Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
, “Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.”, Contemp Clin Trials, vol. 34, no. 2, pp. 196-204, 2013.
, “Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.”, J Subst Abuse Treat, vol. 112S, pp. 41-48, 2020.
, “Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.”, JAMA Ophthalmol, vol. 136, no. 8, pp. 849-856, 2018.
, “An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches”, Front Psychiatry, vol. 12, p. 674691, 2021.
, “PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.”, Addict Sci Clin Pract, vol. 16, no. 1, p. 9, 2021.
, “Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.”, Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
,